front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |review |
Short-acting analogs: Onset - 15 min. Peak - 1-2 hrs. Duration:
4-6 hrs.
Reg.: Onset - 30 - 60 min. Peak:2-4 hrs. Duration: 6-8 hrs.
Glargine: Onset - 2-4 hrs.
Peak: flat. Duration: 24
hrs
R
Insulin analogues offer a much more physiologic insulin profile
than do older insulin preparations
and allow development of a treatment strategy that gives patients much
more dietary freedom using a basal-bolus insulin with carbohydrate
counting.
CSII provides the ultimate in physiologic insulin delivery and
will soon be linked to a continuous
glucose monitoring technology that brings insulin treatment closer to
the dream of a closed loop system or “artificial pancreas”.
|